(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

RADDISH

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

RADDISH

ST13

US500000098116944

Class

35, 36, 42, 44

Filing

98116944

Registration

8254423

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

29

Latest update

05/12/2026

Trademark type

Word

Nice classes

35, 36, 42, 44

Filing date

08/04/2023

Registration date

05/12/2026

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

05/12/2026

Last transaction

05/12/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

06/30/2025

First use in commerce

06/30/2025

Drawing code

4

Owner type

03

Owner location

Washington, DC, US

Examiner

CHONG, JESSICA EUNKYO

Law office

L50

Current location

TMEG LAW OFFICE 105

Holders and representatives

Holders

Global Alzheimer's Platform Foundation Inc.

Representatives

Christopher A. Proskey BROWNWINICK LAW FIRM

Technical classification

Nice Classes

Class 35Class 36Class 42Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 35

Promoting public awareness of Alzheimer'sneurodegenerative diseases and other neurological and central nervous system diseases and issues related thereto in the nature of patient registriespatient researchpatient advocacy and patient fundraising efforts; Promoting public awareness of health care issues for patients with Alzheimer'sneurodegenerative diseases and other neurological and central nervous system diseasesthe importance of patient registration on Alzheimer'sneurodegenerative diseases and other neurological and central nervous system disease registries; Charitable servicesorganizing and developing programs that aim to improve the lives of patients with Alzheimer'sneurodegenerative diseases and other neurological and central nervous system disease patientstheir caregivers and families; Charitable business servicesadministration of programs for enabling participants to receive services for Alzheimer'sneurodegenerative diseases and other neurological and central nervous system disease patientstheir caregivers and families; Business servicesrecruitment of participants for neuroscience clinical research; Maintaining a registry of participants for neuroscience clinical research relating to the treatment and prevention of brain disease; Promoting participation in clinical trials and research in the neuroscience field; Recruitment advertising servicesadvertising clinical trials for the purpose of recruiting patients and placing patients for participation in clinical trials in the neuroscience field

Class 36

Charitable fundraising; Charitable fundraising for Alzheimer's disease and neurodegenerative disease research and treatment

Class 42

Scientific research in the nature of conducting clinical trials and research for others in the field of Alzheimer'sneuro degenerative diseases and other neurological and central nervous system diseases; Medical and scientific researchconducting clinical trials for others; Medical and scientific researchconducting clinical trials for patients with Alzheimer'sneurodegenerative diseases and other neurological and central nervous system diseases

Class 44

Healthcare services; Healthcare servicesadministering care to patients; Healthcare servicesadministering care to patients with Alzheimer'sneurodegenerative diseases and other neurological and central nervous system diseases; Healthcare servicesadministering tests for patients with Alzheimer'sneurodegenerative diseases and other neurological and central nervous system diseases; Healthcare servicestaking samples from patients with Alzheimer'sneurodegenerative diseases and other neurological and central nervous system diseases; Establishing tissuebloodsorganstem cell bank of biological samples related to Alzheimer's neurodegenerative diseases and other neurological and central nervous system diseases; Providing health screening services in the field of Alzheimer'sneurodegenerative diseasesother neurological and central nervous system diseases; Providing health screening services related to Alzheimer'sneurodegenerative diseases and other neurological and central nervous system diseases

Publications

History of USPTO decisions and trademark events.

29 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

05/12/2026

R.PR

REGISTERED-PRINCIPAL REGISTER

05/12/2026

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

04/17/2026

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

04/17/2026

SUPC

STATEMENT OF USE PROCESSING COMPLETE

04/01/2026

IUAF

USE AMENDMENT FILED

10/14/2025

EISU

TEAS STATEMENT OF USE RECEIVED

10/14/2025

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

04/12/2025

EX1G

SOU EXTENSION 1 GRANTED

04/12/2025

EXT1

SOU EXTENSION 1 FILED

04/11/2025

EEXT

SOU TEAS EXTENSION RECEIVED

04/11/2025

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

10/15/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

08/20/2024

PUBO

PUBLISHED FOR OPPOSITION

08/20/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

07/31/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

07/17/2024

XAEC

EXAMINER'S AMENDMENT ENTERED

07/16/2024

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

07/16/2024

GNEA

EXAMINERS AMENDMENT E-MAILED

07/16/2024

CNEA

EXAMINERS AMENDMENT -WRITTEN

07/16/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

07/08/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

07/08/2024

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

07/08/2024

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

04/08/2024

GNRT

NON-FINAL ACTION E-MAILED

04/08/2024

CNRT

NON-FINAL ACTION WRITTEN

04/08/2024

DOCK

ASSIGNED TO EXAMINER

04/05/2024

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

09/03/2023

NWAP

NEW APPLICATION ENTERED

08/08/2023

Continuous trademark protection

Get notified about every new filing that threatens RADDISH or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.